Trends and Outcomes in Lung Transplantation in Patients with and without Idiopathic Pulmonary Fibrosis in Spain during the Period 2016-2020

被引:0
|
作者
Ballesteros, Belen Lopez-Muniz [1 ]
Lopez-de-Andres, Ana [2 ]
Jimenez-Garcia, Rodrigo [2 ]
Zamorano-Leon, Jose J. [2 ]
Carabantes-Alarcon, David [2 ]
Cuadrado-Corrales, Natividad [2 ]
Del-Barrio, Jose L. [3 ]
Perez-Farinos, Napoleon [4 ]
De Miguel-Diez, Javier [5 ]
机构
[1] Hosp Univ Infanta Leonor, Resp Dept, Madrid 28031, Spain
[2] Univ Complutense Madrid, Fac Med, Dept Publ Hlth & Maternal & Child Hlth, Madrid 28040, Spain
[3] Univ Rey Juan Carlos, Hlth Sci Fac, Prevent Med & Publ Hlth Teaching & Res Unit, Alcorcon 28933, Spain
[4] Univ Malaga, Sch Med, Inst Invest Biomed Malaga IBIMA, Epi PHAAN Res Grp, Malaga 29071, Spain
[5] Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon IiSGM, Fac Med,Resp Dept, Madrid 28040, Spain
关键词
lung transplant; idiopathic pulmonary fibrosis; incidence; complications; in-hospital mortality; COVID-19; pandemic; INTERNATIONAL SOCIETY; RISK-FACTORS; ADULT LUNG; GRAFT DYSFUNCTION; ALLOCATION SCORE; REGISTRY; HEART; FOCUS; MORTALITY; SURVIVAL;
D O I
10.3390/healthcare11111534
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
(1) Background: This paper aims to assess temporal trends (2016-2020) in incidence, patient's characteristics, complications, length of hospital stay (LOHS) and in-hospital mortality (IHM) among patients with and without idiopathic pulmonary fibrosis (IPF) undergoing lung transplantation (LTx). We also analyse the effect of the COVID-19 pandemic on LTx in these populations. (2) Methods: A retrospective, population-based observational study was conducted using the Spanish National Hospital Discharge Database. Multivariable adjustment was conducted with logistic regression to analyse the IHM. (3) Results: We identified 1777 admissions for LTx during the study period, of which 573 (32.2%) were performed in patients with IPF. The number of hospital admissions for LTx rose from 2016 to 2020, both in patients with and without IPF, but a marked reduction was observed from year 2019 to year 2020. Over time, the proportion of single LTx decreased and bilateral LTx increased significantly in both groups. The incidence of LTx complications increased significantly over time along with the increase in the incidence of IPF. No significant differences in the incidence of complications or in the IHM between patients with and without IPF were found. Suffering any complication of the LTx and pulmonary hypertension were conditions positively associated with IHM in patients with and without IPF. The IHM remained stable from 2016 to 2020 in both study populations and was not affected by the COVID pandemic. (4) Conclusions: Patients with IPF account for almost a third of all lung transplants. The number of LTx increased over time in patients with and without IPF, but a marked reduction was observed from 2019 to 2020. Although the proportion of LTx complications increased significantly over time in both groups, the IHM did not change. IPF was not associated with increased complications or IHM after LTx.
引用
收藏
页数:14
相关论文
共 45 条
  • [31] Patients with idiopathic pulmonary fibrosis with and without obstructive sleep apnea: differences in clinical characteristics, clinical outcomes, and the effect of PAP treatment
    Papadogiannis, George
    Bouloukaki, Izolde
    Mermigkis, Charalampos
    Michelakis, Stylianos
    Ermidou, Christina
    Mauroudi, Eleni
    Moniaki, Violeta
    Tzanakis, Nikolaos
    Antoniou, Katerina M.
    Schiza, Sophia E.
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2021, 17 (03): : 533 - 544
  • [32] Outcomes of Lung Transplantation in Patients With Combined Pulmonary Fibrosis and Emphysema: A Single-Center Experience
    Narula, Tathagat
    Martin, Archer K.
    Asif, Abuzar A.
    Fritz, Ashley, V
    Li, Zhuo
    Erasmus, David B.
    Alvarez, Francisco
    Thomas, Mathew
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (02) : 449 - 455
  • [33] Potential functional and survival benefit of double over single lung transplantation for selected patients with idiopathic pulmonary fibrosis
    Neurohr, Claus
    Huppmann, Patrick
    Thum, Dolores
    Leuschner, Werner
    von Wulffen, Werner
    Meis, Tobias
    Leuchte, Hanno
    Baumgartner, Rainer
    Zimmermann, Gregor
    Hatz, Rudolf
    Czerner, Stephan
    Frey, Lorenz
    Ueberfuhr, Peter
    Bittmann, Iris
    Behr, Juergen
    TRANSPLANT INTERNATIONAL, 2010, 23 (09) : 887 - 896
  • [34] Post-transplant survival in idiopathic pulmonary fibrosis patients concurrently Listed for single and double Lung transplantation
    Chauhan, Dhaval
    Karanam, Ashwin B.
    Merlo, Aurelie
    Bozzay, Tom
    Zucker, Mark J.
    Seethamraju, Harish
    Shariati, Nazly
    Russo, Mark J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (05) : 657 - 660
  • [35] Effect of antifibrotic therapy in patients with idiopathic pulmonary fibrosis undergoing lung transplant in the peri and post-operative period
    Dorey-Stein, Zachariah L.
    Shapiro, William
    Zhao, Huaqing
    Cordova, Francis C.
    Criner, Gerard J.
    Galli, Jonathan A.
    RESPIRATORY MEDICINE, 2021, 190
  • [36] Perioperative Outcomes During Double-Lung Transplantation and Retransplantation in Cystic Fibrosis Patients: A Monocentric Cohort Study
    Fessler, Julien
    Glorion, Matthieu
    Finet, Michael
    Soniak, Claire
    de Verdiere, Sylvie Colin
    Sage, Edouard
    Roux, Antoine
    Zuber, Benjamin
    Fischler, Marc
    Le Guen, Morgan
    Vallee, Alexandre
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2023, 37 (06) : 964 - 971
  • [37] Differences in cerebral oxygenation during exercise in patients with idiopathic pulmonary fibrosis with and without exertional hypoxemia: does exercise intensity matter?
    Dipla, K.
    Boutou, A. K.
    Markopoulou, A.
    Papadopoulos, S.
    Kritikou, S.
    Pitsiou, G.
    Stanopoulos, I
    Kioumis, I
    Zafeiridis, A.
    PULMONOLOGY, 2023, 29 (03): : 221 - 229
  • [38] Transbronchial lung biopsy in patients with diffuse parenchymal lung disease without 'idiopathic pulmonary fibrosis pattern' on HRCT scan - Experience from a tertiary care center of North India
    Sindhwani, Girish
    Shirazi, Nadia
    Sodhi, Rakhee
    Raghuvanshi, Shailendra
    Rawat, Jagdish
    LUNG INDIA, 2015, 32 (05) : 453 - 456
  • [39] Temporal trends and outcomes of heart transplantation in Spain (2002-2021): propensity score matching analysis to compare patients with and without type 2 diabetes
    Lopez-De-Andres, Ana
    Jimenez-Garcia, Rodrigo
    Hernandez-Barrera, Valentin
    Carabantes-Alarcon, David
    Zamorano-Leon, Jose J.
    Palanco, Ricardo Omana
    Del-Barrio, Jose L.
    De-Miguel-Diez, Javier
    De-Miguel-Yanes, Jose M.
    Cuadrado-Corrales, Natividad
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [40] Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administration
    Ikeda, Satoshi
    Sekine, Akimasa
    Baba, Tomohisa
    Kato, Terufumi
    Katano, Takuma
    Tabata, Erina
    Shintani, Ryota
    Yamakawa, Hideaki
    Oda, Tsuneyuki
    Okuda, Ryo
    Kitamura, Hideya
    Iwasawa, Tae
    Takemura, Tamiko
    Ogura, Takashi
    MEDICINE, 2022, 101 (22) : E29232